Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 9, doi. 10.1002/pu.30848
- Publication type:
- Article
Works matching IS 10685308 AND DT 2022 AND VI 33 AND IP 3
Results: 12
1
2
No increased risk of death from COVID‐19 with antipsychotic treatment.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 8, doi. 10.1002/pu.30847
- Publication type:
- Article
3
THC not more effective than placebo in reducing repetitive behaviors.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 8, doi. 10.1002/pu.30846
- Publication type:
- Article
4
Study suggests use of SSRIs could reduce COVID‐19 severity.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 8, doi. 10.1002/pu.30845
- Publication type:
- Article
5
SSRIs show rapid effects in post‐COVID depression.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 8, doi. 10.1002/pu.30844
- Publication type:
- Article
6
Deutetrabenazine safe and effective for tardive dyskinesia in adults, regardless of age.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 6, doi. 10.1002/pu.30843
- Publication type:
- Article
7
Psychopharmacology research: Pandemic reverberations.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 7, doi. 10.1002/pu.30842
- Publication type:
- Article
8
Maternal antidepressant use linked to small decline in children's mathematics scores.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 4, doi. 10.1002/pu.30841
- Publication type:
- Article
9
Antipsychotic continuation in pregnancy not linked to risk of psychiatric disorders in offspring.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 3, doi. 10.1002/pu.30840
- Publication type:
- Article
10
Valproate and clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 2, doi. 10.1002/pu.30839
- Publication type:
- Article
11
Pimavanserin lowers negative symptoms of schizophrenia in Phase 2 trial.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 1, doi. 10.1002/pu.30838
- Publication type:
- Article
12
Lithium shows no preventive benefit in veterans surviving suicide attempt.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 3, p. 1, doi. 10.1002/pu.30837
- Publication type:
- Article